6
Ease wound treatment in long term care patients with clinically proven ALLEVYN Foam Dressings Recognize Reduce

Recognize Reduce and...Poster presentation; WOCN Society & CAET Joint Conference, June 4-8, 2016. 5. Forni C, Searle R. Economic evaluation of the use of a multi-layer polyurethane

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Recognize Reduce and...Poster presentation; WOCN Society & CAET Joint Conference, June 4-8, 2016. 5. Forni C, Searle R. Economic evaluation of the use of a multi-layer polyurethane

Ease wound treatment in long term care patients with clinically proven ALLEVYN Foam Dressings

Recognize Reduce

Page 2: Recognize Reduce and...Poster presentation; WOCN Society & CAET Joint Conference, June 4-8, 2016. 5. Forni C, Searle R. Economic evaluation of the use of a multi-layer polyurethane

Recognizing the problem

66% of patients with urinary incontinence are more likely to develop pressure injuries1

56% of patients with limited bed mobility are more likely to develop pressure injuries1

48% of patients with diabetes/PVD are more likely to develop pressure injuries1

11 billionis spent annually on treating pressure injuries in the US2

Centers for Medicare & Medicaid Services associates facility-acquired pressure injuries (FAPIs) to omission of care¹

• Hoyer lifts• Wheelchairs• Intubation tubing

• Catheters • Cervical collars• Casts

Patient risk

Cost burden

Occurrence

of pressure injuries result from residence care3

69.6% 87.8 %of pressure injuries that occur are considered preventable3

Medical device related risk

Page 3: Recognize Reduce and...Poster presentation; WOCN Society & CAET Joint Conference, June 4-8, 2016. 5. Forni C, Searle R. Economic evaluation of the use of a multi-layer polyurethane

inci

denc

e of

pre

ssur

e in

jurie

s

Standard care Standard care + ALLEVYN

GENTLE BORDER

40

35

30

25

20

15

10

5

0

Reduce FAPIs with clinically proven ALLEVYN™

ALLEVYN LIFE was introduced as part of a comprehensive pressure injury prevention program in 49 skilled care communities. Their goal was to reduce the incidence of FAPIs by 55%.4

In addition to standard preventive care, ALLEVYN GENTLE BORDER helped reduce the incidence of pressure injuries in critically ill patients admitted to the ICU.6

90% relative reduction in Stage 1 pressure injury incidence (p=0.006)6

65% relative reductionin impaired skin integrity6

26% relative reductionin incidence of blanchingerythema6

Compared to standard preventive care alone, ALLEVYN LIFE has been shown to reduce per patient cost up to

69%5

5

44.5

3.53

2.52

11.5

00.5

August 2013

4.5%

0.62%0.67%

January 2014

85%

FAPI rate

reduction in FAPIs following introduction of new protocol that included ALLEVYN LIFE

29% N=35

2.9% N=31

June 2014

6

Page 4: Recognize Reduce and...Poster presentation; WOCN Society & CAET Joint Conference, June 4-8, 2016. 5. Forni C, Searle R. Economic evaluation of the use of a multi-layer polyurethane

The right dressing at the right time

The right dressing for the right patient

ALLEVYN LIFEFor patients with highly exudating chronic wounds• with drainage that threaten

dressing adhesion• with limited mobility• who would benefit from

advanced lock-in and masking technologies that reduce odors

ALLEVYN LIFE One More DayFor active patients with low to moderate exudating chronic wounds • who are engaged in their own

care • who want less frequent dressing

changes• who are comfortable and trust

advanced medical technologies

ALLEVYN Gentle BorderFor patients with low to moderate exudating chronic wounds • with risk of complications• who require frequent application

and removal• who would benefit from a quality

silicone dressing that is highly adaptable to any position and stays in place

  ALLEVYN™ LIFE ALLEVYN™ GENTLE BORDER ALLEVYN™ GENTLE BORDER LITE

Change indicator

Wear time Up to7 Days* Up to 7 Days* Up to 7 Days

Pressure injury prevention  

Exudate level High Medium Low

Shower proof

Suggested use High Exudate/PIP Moderate Exudate/ MDRPIP Daily Dressing Changes

*On sacrum, up to 5 days

Kevin BrendaPatty

Page 5: Recognize Reduce and...Poster presentation; WOCN Society & CAET Joint Conference, June 4-8, 2016. 5. Forni C, Searle R. Economic evaluation of the use of a multi-layer polyurethane

mean increase +1.9 days in wear time +52.9%

Reduce the burden of wound care

Reduce the burden of exudate management

Preventing pressure injuries before they begin could reduce:1,3

• Patient discomfort

• Hospital readmissions

• Medicare penalties

• Wound complications

Excellent fluid management

vs.

Mean wear time of previously used foam dressings 3.4 days (N=70)

mean wear time with ALLEVYN LIFE Dressing 5.2 days (N=70)

50% reductions in dressing change visit frequency.

*Tested on MepilexTM Border

Lasts nearly 2x longer than other dressings12*

Percentage of dressings with leakage (in vitro)7*

ALLEVYN™ LIFE Traditional silicone dressing*

Minimizes leakage with high absorption and locking-in of fluid.8,9

Maintains a moist wound environment with minimal risk of skin damage8,10,11

0% 64%

Page 6: Recognize Reduce and...Poster presentation; WOCN Society & CAET Joint Conference, June 4-8, 2016. 5. Forni C, Searle R. Economic evaluation of the use of a multi-layer polyurethane

Treat more with less. Order ALLEVYN™ for your patients today

Product code Dressing sizes (border to border)

ALLEVYN LIFE

66801067 4in x 4in66801068 5in x 5in66801069 6in x 6in66801070 8in x 8in66801304 Heel 9.8in x 9.9in66801306 Sacrum Small 6¾in x 67/8in66801307 Sacrum Large 8½in x 9in

ALLEVYN LIFE Non-Bordered

66801747 21/8 in x 21/8 in66801748 4in x 4in66801749 6in x 6in66801750 81/4 in x 81/4 in66801751 4in x 8in66801752 8in x 19¾in

ALLEVYN GENTLE BORDER

66800276 3in x 3in66800270 4in x 4in66800279 5in x 5in66800280 7in x 7in66800900 4in x 8in 66800264 4in x 10in66800265 4in x 12in66800506 Heel 9in x 9in66800959 Multisite 6¾in x 71/16in66800898 Sacrum 6in x6¾in66801031 Sacrum 8½in x 9in

Product code Dressing sizes (border to border)

ALLEVYN GENTLE BORDER LITE

66800833 2in x2in66800836 21/8 in x 4¾in66800834 3in x 3in66800835 4in x 4in66800840 6in x 6in

ALLEVYN GENTLE (Non-Bordered)

66802128 2in x 2in66802129 4in x 4in66802130 4in x 8in66802131 6in x 6in66802132 8in x 8in66802133 8in x 20in

For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.

References

1. Julie Seibert, PhD, MPH, MA, Jennifer Frank, MPH, Amarilys Bernacet, MPH, et al, Technical Expert Panel Summary Report: Refinement of a Cross-Setting Pressure Ulcer/Injury Quality Measure for Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals and Home Health Agencies, Centers for Medicare & Medicaid Services, August 2019 2. Agency for Healthcare Research and Quality website. Preventing pressure ulcers in hospitals: a toolkit for improving quality of care. https://www.ahrq.gov/professionals/systems/hospital/ pressureulcertoolkit/putool1.html. Updated October 2014. Accessed February 1, 2018 3. Alok Kapoor, MD, MSc, Terry Field, DSc, Steven Handler, MD, PhD, CMD, et al., Adverse Events in Long-term Care Residents Transitioning from Hospital Back To Nursing Home, JAMA Intern Med. 2019;179(9):1254-1261. doi:10.1001/jamainternmed.2019.2005 4. Turbett K. Project to reduce pressureulcers/injuries in 49 skilled care communities. Poster presentation; WOCN Society & CAET Joint Conference, June 4-8, 2016. 5. Forni C, Searle R. Economic evaluation of the use of a multi-layer polyurethane foam dressing for the prevention of pressure ulcers in elderly patients with hip fractures. Poster presented at EPUAP annual meeting, September 2018. 6. Lee YJ, Kim JY, Shin WY, Yeon YH. Use of prophylactic silicone adhesive dressings for maintaining skin integrity in intensive care unit patients: A randomised controlled trial. Int Wound J. 2019;16(Suppl 1):36-42. 7. Stephen-Haynes J, Bielby A, Searle R. The clinical performance of a silicone foam in an NHS community trust. Journal of Community Nursing. 2013;27(5):50-59. 8. Smith & Nephew data on file report DS/12/130/DOF. Simulated wound model testing of ALLEVYN LIFE and Mepilex Border. 9. Data on File Report DS/14/303R – April 2016, K. Earl. Wound Model Testing of ALLEVYN LIFE Gen2 using Horse Serum 10. Rossington, A. et al (2013) Clinical performance and positive impact on patient wellbeing of ALLEVYN Life. Wounds UK. 9(4): 91-95 11. Rossington, A. Pressure transmission testing of ALLEVYN LIFE when wet and dry, MepilexTM Border and OptifoamTM Gentle. Data on File report DS/18/351R- September 2018 12. Joy H et al. A collaborative project to enhance efficiency through dressing change practice. Journal of Wound Care. Vol 24. No 7. July 2015 P3-4

™Trademark of Smith & Nephew ©2020 Smith & Nephew ALPE1-23022-0120

Advanced Wound Management

Smith & Nephew Fort Worth, TX 76109USA

www.smith-nephew.com 1 800 876-1261T 727 392-1261F 727 392-6914

Prior to ordering, consider the following:1. Does your distributor have a contract with

Smith + Nephew?2. Is your chain a member of a GPO?3. Is ALLEVYN on your PPD?